The Barth Syndrome Foundation (BSF) invites researchers to submit proposals for the organization’s Research Grant Program. The BSF offers funding for basic clinical and scientific research on the biochemical basis, natural history, and treatment of Barth syndrome. Since 2002, the BSF has awarded over $2.7 million to investigators studying this condition.
Barth syndrome (BTHS) is a rare, x-linked genetic disorder primarily affecting males around the world. The cardinal characteristics of this multi- system disorder consist of the following in varying degrees: cardiomyopathy, neutropenia, muscle hypoplasia and weakness, exercise intolerance, growth delay, 3 methylglutaconic aciduria, and cardiolipin deficiency.
The BSF encourages all investigators at every professional level to submit their best ideas for advancing the state of knowledge about BTHS, so that progress can be made in finding a specific treatment or cure for this unusual mitochondrial disease. The BSF provides “seed grant funding” in order to encourage young investigators, as well as to attract experienced investigators new to the field of Barth Syndrome basic science or clinical research.
The BSF anticipates that these funds will be used to test initial hypotheses and to support the collection of preliminary data leading to successful long- term funding by the National Institutes of Health and other major granting institutions around the world.
To learn more about the BSF, see the Foundation’s website. For more information about grant opportunities and the BSF’s Research Grant Program, please contact Lindsay B. Groff, M.B.A., BSF executive director, at email@example.com.